首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到19条相似文献,搜索用时 200 毫秒
1.
从基因工程水平构建了小鼠金属硫蛋白与抗人活化血小板单抗SZ51单链抗体的重组基因产物,并在大肠杆菌菌株BL21(DE3)pLysS中成功地进行了表达.该重组蛋白以包涵体形式存在于菌体蛋白中,分子量为38kD,ELISA实验证明该重组蛋白既具有血栓部位活化血小板的单抗活性,又具有小鼠MT单抗的活性  相似文献   

2.
目的:在大肠杆菌中高效表达并纯化VEGF121与两性分子KLAK的融合蛋白,为进一步研究其抗肿瘤血管形成作用奠定基础。方法:用RT-PCR法扩增目的基因,插入表达载体pET28a后,转化大肠杆菌BL21(DE3),经IPTG诱导表达重组蛋白,对产物进行SDS-PAGE及Western印迹分析。结果:克隆出目的基因,构建了融合蛋白表达载体,诱导表达后经SDS-PAGE检测表明获得了目的条带。结论:在大肠杆菌中高效表达并纯化了融合蛋白VEGF121-KLAK。  相似文献   

3.
大肠杆菌中高效表达携带组氨酸标签的人巨细胞病毒皮层蛋白pUL23,并进行纯化以及鉴定.提取感染HCMV Towne病毒株的HFF细胞的总RNA,逆转录为cDNA作为模板,经PCR获得UL23的基因片段,将此片段插入表达载体pET-28a(+),构建pET28a(+)-UL23重组质粒.将pET28a(+)-UL23转化至大肠杆菌BL21( DE3),进行IPTG诱导表达.表达产物经Western blotting分析后进行发酵,再用Ni sepharose亲和层析纯化,纯化产物进行SDS-PAGE和Western blotting检测.结果表明,成功构建pET28a(+)-UL23原核表达载体,表达及纯化了His-pUL23融合蛋白.为进一步研究pUL23奠定基础.  相似文献   

4.
马琼  谢菲  周志  周明 《植物科学学报》1983,37(2):181-187
采用PCR技术从鱼腥藻(Anabaena sp.)PCC 7120中扩增获得红色荧光蛋白基因all1280 gaf2,并利用BamHⅠ和SalⅠ酶切位点,将该基因插入到pET-30a(+)中,构建表达载体pET-all1280 gaf2。将该表达载体与藻胆色素生物合成质粒pACYC-ho1-pcyA同时转化到大肠杆菌E.coli BL21(DE3),表达后获得大肠杆菌色素细胞。结果显示,该色素细胞在荧光显微镜下具有红色荧光,且在15E/15Z态之间具有可逆光效应。进一步以pET-all1280 gaf2为模板,通过定点突变技术在all1280 gaf2基因中引入C53A突变,获得了突变体All1280 GAF2(C53A)。将All1280 GAF2(C53A)与藻胆色素在E.coli BL21(DE3)中共表达,获得了比野生型红色荧光更强的大肠杆菌色素细胞。研究结果表明,与野生型相比,All1280 GAF2(C53A)具有较高的摩尔消光系数和荧光量子产率,红色荧光更强。  相似文献   

5.
采用PCR技术从鱼腥藻(Anabaena sp.) PCC 7120中扩增获得红色荧光蛋白基因all1280 gaf2,并利用Bam HⅠ和SalⅠ酶切位点,将该基因插入到pET-30a(+)中,构建表达载体pET-all1280 gaf2。将该表达载体与藻胆色素生物合成质粒pACYC-ho1-pcyA同时转化到大肠杆菌E. coli BL21 (DE3),表达后获得大肠杆菌色素细胞。结果显示,该色素细胞在荧光显微镜下具有红色荧光,且在15E/15Z态之间具有可逆光效应。进一步以pET-all1280 gaf2为模板,通过定点突变技术在all1280 gaf2基因中引入C53A突变,获得了突变体All1280 GAF2 (C53A)。将All1280 GAF2 (C53A)与藻胆色素在E. coli BL21 (DE3)中共表达,获得了比野生型红色荧光更强的大肠杆菌色素细胞。研究结果表明,与野生型相比,All1280 GAF2 (C53A)具有较高的摩尔消光系数和荧光量子产率,红色荧光更强。  相似文献   

6.
以大肠杆菌基因组DNA为模板,设计引物扩增得到天冬氨酸酶基因,将其重组于胞内融合表达型T载体中,重组质粒转化表达宿主大肠杆菌BL21(DE3)。SDS-PAGE分析表明,工程菌经IPTG诱导,表达大量表观分子量约75kD的融合蛋白。经试验,工程菌细胞具有较高的天冬氨酸酶活性,融合形式的酶最适温度37℃,最适pH8.5,融合伴侣DsbA的存在对酶活没有影响。  相似文献   

7.
衣藻CrFtsZ2-GFP融合蛋白在E.coli中的表达及其定位   总被引:2,自引:0,他引:2  
FtsZ蛋白在细菌的分裂中担任着重要作用 ,能够在分裂位点形成一个环状结构而控制细菌的分裂过程。胞内FtsZ蛋白浓度的异常升高或降低均可阻断正常的细胞分裂过程进而形成分裂异常的丝状菌体。为了研究衣藻FtsZ蛋白的生物学活性 ,构建了衣藻CrFtsZ2cDNA全长与绿色荧光蛋白基因egfp的融合表达质粒 ,并对其在大肠杆菌中的表达与定位做了初步分析。在大肠杆菌JM10 9中 ,融合表达质粒的过量表达导致宿主菌形成了丝状菌体 ,通过荧光显微镜观察发现CrFtsZ2 EGFP融合蛋白沿着宿主菌体的纵轴方向有规律地聚集成荧光点或荧光带 ,暗示衣藻CrFtsZ2蛋白能够识别宿主菌内分裂位点的定位信号并参与其细胞分裂过程 ,初步验证了衣藻CrFtsZ2蛋白的功能。  相似文献   

8.
采用PCR技术从E.coli基因组片中克隆出碱性磷酸酯酶的启动子和信号肽序列,在PhoA启动子5端设计了EcoRⅠ酶位点,在信号肽编码序列3端设计了HindⅢ酶切位点,将PCR产物酶切后EcoRⅠ-HindⅢ片段克隆至pBR322的EcoRⅠ-HindⅢ倍点,组构出含有PhoA启动子和信号肽序列的分泌表达载体pBM-Pho-,之后将人表皮生长因子的成熟肽基因克隆至该载体,使之有E.coli中获得分  相似文献   

9.
大肠杆菌高密度发酵以包涵体形式表达融合蛋白Trx-rPA,表达量22%。包涵体蛋白洗涤后经金属螯合层析纯化,纯度达80%以上。经胱氨酸衍生,以脉冲加样形式复性,复性率可高达30%。经ETI-Sepharose纯化,复性的融合蛋白生物活性可达3.5×105IU/mgPr.。融合蛋白可被rEK酶切释放rPA,酶切效率达85%以上。酶切液经IDA-Sepharose和SP-Sepharose层析纯化,rPA纯度达98%以上,生物活性50万IU/mgPr.。1L发酵液经分离、复性及纯化后,可得高纯度rPA300mg以上。  相似文献   

10.
重组人生长激素在大肠杆菌BL21(DE3)中高效表达研究   总被引:4,自引:0,他引:4  
对重组人生长激素基因工程菌pET-11b/rhGH/BL21的培养条件进行了优化,在NBS MPP-40发酵罐中实现了高密度培养和高效表达,三批实验结果表明,在较短的发酵时间(12h)内细菌干重达85g/L,重组人生长激素占总蛋白量的25%左右。  相似文献   

11.
目的:lpxM基因失活可以产生极低内毒素活性的脂多糖。构建大肠杆菌BL21(DE3)的lpxM突变株,并考察该突变株的生长状态和表达重组蛋白的能力。方法:构建同源臂长500bp左右的打靶载体,借助Red同源重组系统,使E.coliBL21(DE3)的lpxM基因发生插入失活,再导入编码FLP位点特异性重组酶的质粒pCP20去除抗性基因。PCR鉴定发生插入突变的菌株,应用SDS-PAGE分析突变前后的脂多糖,考查对重组蛋白表达的影响。结果:PCR鉴定结果说明lpxM基因发生了插入突变。与出发株比较,突变株的脂多糖电泳图谱发生了明显变化,但其生长状态与表达重组蛋白的能力与出发株基本一致。结论:大肠杆菌BL21(DE3)的lpxM突变株可以用于重组蛋白的表达。  相似文献   

12.
从E.coli MC4100菌体的染色体DNA中利用鸟枪法克隆含编码肉碱消旋酶及相关因子的caiDE基因片段,并经序列分析验证,由重组质粒plX393亚克隆得到pDSW2重组表达质粒,后者转入E.coli BL21(DE3)菌株中是丙基硫代半乳糖苷(IPTG)诱导,在聚丙烯酰胺凝胶电泳(SDS-PAGE)上分子量为30kD和24kD附近可见明显的表达蛋白带。  相似文献   

13.
目的:研究rimJ基因对大肠杆菌BL21(DE3)菌株生长的温度敏感性的影响。方法:利用SceⅠ-Red同源重组技术将大肠杆菌BL21(DE3)基因组中的rimJ基因缺失,得到rimJ缺失突变菌;比较缺失突变株和原始菌株在不同温度(25℃、37℃、42℃)下的最大比生长速率,利用统计学方法分析rimJ基因的缺失对BL21(DE3)菌株生长的温度敏感性是否有影响。结果:rimJ基因被成功敲除;统计分析结果表明缺失突变株和原始菌株的最大比生长速率没有明显区别。结论:rimJ基因缺失对大肠杆菌BL21(DE3)生长的温度敏感性无影响。  相似文献   

14.
Escherichia coli is one of the most suitable hosts for production of antibodies and antibody fragments. Antibody fragment secretion to the culture medium improves product purity in cell culture and diminishes downstream costs. In this study, E. coli strain BL21 (DE3) harboring gene encoding bispecific anti‐MUC1 nanobody was selected, and the autoinduction methodology for expression of bispecific anti‐MUC1 nanobody was investigated. Due to the replacement of IPTG by lactose as inducer, less impurity and toxicity in the final product were observed. To increase both intracellular and extracellular nanobody production, initially, the experiments were performed for the key factors including temperature and duration of protein expression. The highest amount of nanobody was produced after 21 h at 33°C. The effect of different carbon sources, glycerol, glucose, lactose, and glycine as a medium additive at optimum temperature and time were also assessed by using response surface methodology. The optimized concentrations of carbon sources were obtained as 0.75% (w/v), 0.03% (w/v), 0.1% (w/v), and 0.75% (w/v) for glycerol, glucose, lactose, and glycine, respectively. Finally, the production of nanobody in 2 L fermenter under the optimized autoinduction conditions was evaluated. The results show that the total titer of 87.66 µg/mL anti‐MUC1 nanobody, which is approximately seven times more than the total titer of nanobody produced in LB culture medium, is 12.23 µg/L .  相似文献   

15.
重组刺桐胰蛋白酶抑制剂a在大肠杆菌中的表达和纯化   总被引:2,自引:0,他引:2  
为了大量制备重组刺桐胰蛋白酶抑制剂a(rETIa) ,对构建的基因工程菌株E .coliBL2 1(DE3)pET2 2b mETIa进行了表达条件的优化 .用摇瓶培养 ,rETIa蛋白占菌体总蛋白 4 0 %以上 .经破碎菌体 洗涤包涵体 溶解包涵体 复性初步纯化后 ,再经二步柱层析纯化获得电泳纯的rETIa蛋白 .测定了rETIa对胰蛋白酶、胰凝乳蛋白酶、组织型纤溶酶原激活因子缺失突变体 (NTA)的抑制活性 .  相似文献   

16.
Abstract

The emergence of drug resistance in Streptococcus pneumoniae (Spn) is a global health threat and necessitates discovery of novel therapeutics. The serine acetyltransferase (also known as CysE) is an enzyme of cysteine biosynthesis pathway and is reported to be essential for the survival of several pathogenic bacteria. Therefore, it appears to be a very attractive target for structure–function understanding and inhibitor design. This study describes the molecular cloning of cysE from Spn in the pET21c vector and efforts carried out for expression and purification of active recombinant CysE. Significant expression of recombinant Spn cysE could be achieved in codon optimized BL21(DE3)-RIL strain as opposed to conventional BL21(DE3) strain. Analysis of codon adaptation index (CAI) with levels of eukaryotic genes and prokaryotic cysEs expressed in heterologous E. coli host suggests that codon optimized E. coli BL21(DE3)-RIL may be a better host for expressing genes with low CAI. Here, an efficient protocol has been developed for recovery of recombinant Spn CysE in soluble and biologically active form by the usage of nonionic detergent Triton X-100 at a concentration as low as 1%. Altogether, this study reports a simple strategy for producing functionally active Spn CysE in E. coli.  相似文献   

17.
东亚钳蝎毒素基因BmKIT3 编码是由 6 5个氨基酸残基组成的多肽物质。该类毒素为专一性作用于昆虫的抑制型神经毒素 ,它已被广泛用于研究离子通道作用机理[1 ] ;同时 ,它是研究蛋白质结构和功能的极好模型 ,是研究神经药理学的理想工具 ,将具有药理活性和昆虫毒性的基因导入细胞或动植物体内具有十分重要的应用价值。它对昆虫作用的专一性很高 ,对哺乳动物无害或毒性很小 ,可作为一种安全、有效的生物杀虫剂[2 ,3 ] 。我们的研究是对该基因密码子进行优化 ,采用化学合成的方法合成了适于在昆虫中表达的BmKIT3 的两条长的引物 ,通过…  相似文献   

18.
Escherichia coli BL21 (DE3) is an excellent and widely used host for recombinant protein production. Many variant hosts were developed from BL21 (DE3), but improving the expression of specific proteins remains a major challenge in biotechnology. In this study, we found that when BL21 (DE3) overexpressed glucose dehydrogenase (GDH), a significant industrial enzyme, severe cell autolysis was induced. Subsequently, we observed this phenomenon in the expression of 10 other recombinant proteins. This precludes a further increase of the produced enzyme activity by extending the fermentation time, which is not conducive to the reduction of industrial enzyme production costs. Analysis of membrane structure and messenger RNA expression analysis showed that cells could underwent a form of programmed cell death (PCD) during the autolysis period. However, blocking three known PCD pathways in BL21 (DE3) did not completely alleviate autolysis completely. Consequently, we attempted to develop a strong expression host resistant to autolysis by controlling the speed of recombinant protein expression. To find a more suitable protein expression rate, the high‐ and low‐strength promoter lacUV5 and lac were shuffled and recombined to yield the promoter variants lacUV5‐1A and lac‐1G. The results showed that only one base in lac promoter needs to be changed, and the A at the +1 position was changed to a G, resulting in the improved host BL21 (DE3‐lac1G), which resistant to autolysis. As a consequence, the GDH activity at 43 h was greatly increased from 37.5 to 452.0 U/ml. In scale‐up fermentation, the new host was able to produce the model enzyme with a high rate of 89.55 U/ml/h at 43 h, compared to only 3 U/ml/h achieved using BL21 (DE3). Importantly, BL21 (DE3‐lac1G) also successfully improved the production of 10 other enzymes. The engineered E. coli strain constructed in this study conveniently optimizes recombinant protein overexpression by suppressing cell autolysis, and shows great potential for industrial applications.  相似文献   

19.
Thomas U. Schwartz 《Proteins》2013,81(11):1857-1861
His‐tag affinity purification is one of the most commonly used methods to purify recombinant proteins expressed in E. coli. One drawback of using the His‐tag is the co‐purification of contaminating histidine‐rich E. coli proteins. We engineered a new E. coli expression strain, LOBSTR (lo w b ackground str ain), which eliminates the most abundant contaminants. LOBSTR is derived from the E. coli BL21(DE3) strain and carries genomically modified copies of arnA and slyD, whose protein products exhibit reduced affinities to Ni and Co resins, resulting in a much higher purity of the target protein. The use of LOBSTR enables the pursuit of challenging low‐expressing protein targets by reducing background contamination with no additional purification steps, materials, or costs, and thus pushes the limits of standard His‐tag purifications. Proteins 2013; 81:1857–1861. © 2013 Wiley Periodicals, Inc.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号